Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.

[1]  M. Hristov,et al.  High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population. , 2008, JIM - Journal of Immunological Methods.

[2]  E. Peterson,et al.  Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. , 2007, Journal of the American College of Cardiology.

[3]  M. Yoder,et al.  Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.

[4]  M. Shibuya,et al.  Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. , 2007, Blood.

[5]  A. Balber,et al.  Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. , 2007, Cytotherapy.

[6]  D. Link,et al.  The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.

[7]  J. Whitesides,et al.  Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Doris A Taylor,et al.  Circulating endothelial progenitor cells predict coronary artery disease severity. , 2006, American heart journal.

[9]  H. Miller,et al.  Comparative analysis of methods for assessment of circulating endothelial progenitor cells. , 2006, Tissue engineering.

[10]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[11]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[12]  A. Scheffold,et al.  CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors , 2005, Circulation research.

[13]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[14]  A. Avogaro,et al.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.

[15]  M. Kelm,et al.  Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.

[16]  J. P. McCoy,et al.  Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  G. Schatteman.  Are circulating CD133+ cells biomarkers of vascular disease? , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  G. Nowak,et al.  Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization , 2004, Circulation.

[19]  G. Wichmann,et al.  Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[21]  U. Ikeda,et al.  Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease , 2004, Heart.

[22]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R. Vile,et al.  Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood , 2003, Circulation research.

[24]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[25]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[26]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[27]  D. Soligo,et al.  Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.

[28]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[29]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[30]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[31]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[32]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.